Now Reading
FDA limits use of Janssen vaccine
Subscribe
Sign In

FDA limits use of Janssen vaccine

Authorized use of the J&J vaccine has been restrictednot. Restriction due to risk of blood clots.

Where: US

The Facts

The US health regulator Food and Drug Administration (FDA) has limited the use of Johnson & Johnson’s Covid-19 vaccine for adults.
The J&J vaccine can be used in cases where approved Covid-19 vaccines are not accessible or clinically appropriate or if an individual elects to receive the vaccine.
The authorized use of the vaccine has been limited because of the risk of thrombosis with thrombocytopenia (TTS).
Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research stated, “Our action reflects our updated analysis of the risk of TTS following administration of this vaccine and limits the use of the vaccine to certain individuals.”
J & J is one of the three vaccines in use in the US, the other two being from Moderna and Pfizer.

Primary Sources

Direct, authoritative source material on this story.

Reference Articles

Articles Citable has ingested related to this story.

Reference Articles

Articles Citable has ingested related to this story.

Media Coverage

Why did we include this story

Most covered story by the media today

of articles referenced this story

Coverage by Media Outlet

Media outlets covering this story along with their positive or negative sentiment toward this story.

© 2021 Citable. All Rights Reserved.